VALENCIA, Calif., Feb. 21 /PRNewswire-FirstCall/ -- MannKind Corporation , focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Citigroup Global Healthcare Conference to be held February 27 - March 1, 2006 at The Mayflower Hotel in Washington, D.C.
Management is scheduled to speak on Wednesday, March 1, 2006 at 10:20 a.m. Eastern Time (7:20 a.m. PST). Management will provide an update on the Company.
Interested parties can access a link to the live web cast of each presentation in the Investor Relations section of the Company’s website at www.mannkindcorp.com. A replay of each presentation will be available for 14 days.
About MannKind Corporation
MannKind Corporation focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Its lead investigational product candidate, the Technosphere(R) Insulin System, is currently in phase 3 clinical trials in the U.S. and Europe to study its safety and efficacy in the treatment of diabetes. For more information on MannKind Corporation and its technology, visit www.mannkindcorp.com.
MannKind Corporation
CONTACT: Dick Anderson, Chief Financial Officer of MannKind Corporation,+1-661-775-5302, danderson@mannkindcorp.com; or Investor Relations, JulieHuang of Financial Dynamics, +1-212-850-5628, Julie.Huang@fd.com, forMannKind Corporation
Web site: http://www.mannkindcorp.com/
